Indications of low-molecular weight haparins in elderly patients;Indication des héparines de bas poids moléculaire chez les malades âgés

Revue de Geriatrie

Volumn 21, Issue 7, 1996, Pages 459-468

  Manciet, G ^c   Richard, S ^a   Albert, D ^a   Vergnes, C ^b   Emeriau, J P ^a   Boisseau, M R ^b  

^a Service de Médecine Interne   (France)

^b Groupe Hospitalier Sud CHU de Bordeaux   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

AGED; AGING; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG SAFETY; GERIATRICS; HUMAN; META ANALYSIS; SHORT SURVEY; THROMBOSIS;

EID: 0030428253     PISSN: 03977927     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. SAMAMA M M., BARA L., GEROTZIAFAS G.T Mechanisms for the antithrombotic activity in man of low molecular weight heparins (LMWH) Haemostasis∼ 1994; 24: 105-117.
2. BONEU B., CARANOBE C , SIE P. Pharmacokmetics of heparin and low molecular weight heparin. Baillere's Clinical Haematology, 1990; 3. 531-544.
3. ANDERSON F.A., WHEELER H B., GOLBERG R.J. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester D.V.T study Arch. Intern Med., 1991; 151 933-938.
4. KNIFFIN W D., BARON J A., BARRETT J., BIRKMEYER J D., ANDERSON J.A. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch. Int. Med , 1994, 154 861-866
5. EUROPEAN CONSENSUS STATEMENT. Prevention of venous thromboembolism Int. Angiology, 1992, 11: 151-159.
6. NURMOHAMED M.T . ROSENDAAL F R , BULLER H.R., DEKKER E , HOMMES D N , VANDENBROUCKE J.P , BRIET E Low-molecular weight heparin versus standard heparin in general and orthopaedic surgery a metaanalysis Lancet, 1992; 340 : 152-155.
7. LEIZOROVICZ A., HAUGH M.C., CHAPUIS F R , SAMAMA M.M , BOISSEL J.P Low molecular weight heparin in prevention of perioperative thrombosis Br Med J., 1992: 305. 913-20.
8. HULL R , RASKOB G . PINEO G. and al A comparison of subcutaneous low-molecular-weight-heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hir or knee implantation. N. Engl J Med ,1993, 329 : 1370-6
9. SCURR J.H , COLERIDGE-SMITH P.D., HASTY J.H. Deep venous thrombosis: a continuing problem. Br Med J., 1988; 297, 28.
10. DAHAN R., HOULBERT D , CAULIN C., CUZIN E . VILTART C. Prevention of deep vein thrombosis in elderly medical in patients by a low molecular weight heparin. a randomized double-blind trial. Haemostasis. 1986, 16 :159-164
11. AQUINO J.P , GAMBIER A., DUCROS J. Prevention of thromboembolic accidents in elderly subjects with Fraxiparine In Fraxiparine. Second International Symposium. Recent Pharmacological and Clinical Data H BOUNAMEAUX, MM SAMAMA, J W TEN CATE, Eds. SHATTAUER, Stuttgart-New York 1990 pp 51-54
12. FORETTE B., WOLMARK Y Nadropanne Calcique dans la prévention de la maladie thrombo-embolique chez le sujet âgé Etude de la tolérance. Press. Med., 1995; 24: 567-571
13. MANCET G., VERGNES C. VAISSIE J J , BOISSEAU M R A study on the efficacy and tolerance of Fraxiparine during long-term therapy of the elderly. A randomized double-blind clinical trial In Fraxiparine, 2nd International Symposium. Recent Pharmacological and Clinical Data, H. BOUNAMEAUX, M. SAMAMA, J W. TEN CATE, Eds SHATTAUER, Stuttgent - New York 1990, pp 55-59.
14. MANCET G , VERGNES C , LOUVET P J., BECERRO M and al Incidence of deep venous thrombosis in disabled elderly. Interest of iterative D-Dimer assays 16th World Congress of the International Union of Angiology, Paris, 13-18 septembre 1992 (Abstract).
15. MANCIET G , LAUBIER M F., LOUVET P J et coll Prescription des héparines de bas poids moléculaire (HBPM) en médecine génatrique. Pourquoi ? Comment ? Rev. Med. Int., 1993, 14 .1076
16. ANDERSON F A., WHEELER H.B Strategies to improve implementation. In Prevention of venous thromboembolism SZ GOLDHABER Ed Marcel Dekker Inc , New York Basel, Hong Kong, 1992 pp 519-39.
17. AUZI G. Mise en place d'un protocole de prévention des thromboses veineuses profondes chez la personne âgée Thèse pour le Doctorat d'Etat en Pharmacie, Université de Bordeaux II, 1995, Thèse no 57
18. DUROUX P. A randomized trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionnated heparin in the treatment of deep vein thrombosis Thrombosis and Haemostasis, 1991; 65 251-256.
19. PRANDONI P Comparison of subcutaneous low-molecular weight heparin with intravenous standard heperin in proximal dee∼vein-thrombosis Lancet, 1992: 339: 441-445.
20. HULL R D RAJKOB G E . PrNEO G F and al Subcutaneous low-molecular weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis N. Engl. J Med 1992: 326 975-982
21. LEIZOROVICZ A , SIMONNEAU G . DECOUSUS H , BOISSEL J P Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis a metaanalysis Br Med J , 1994 309 299-304.
22. LENSING A W A. PRINS M.H DAVSDSON B.L HIRSH J Treatment of deep venous thrombosis, with low-molecular-weight heparins Arch Intern Med , 1995: 155 601-607
23. HIRSH J SIRAGLISA S COSMI B . GINSBERG J S Low molecular weight heparins (LMWH) in the treatment of patients with acute venous thromboembolism Thrombosis Haemostasis, 1995 74: 360-3
24. KOOPMAN M M N., PRANDONI P . PIOVELLA F and al Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home N Engl. J Med , 1996, 334 682-7
25. LEVINE M GENT M . HIRSH J, and al A comparison of low-molecular-weight heparin administered at home with unfractionated heparin administered in the hospital for proximal deep-vein-thrombosis N. Engl J Med 1996; 334: 677-81
26. GUINIER M.C., GAUTHIER O , CHATELAN M., LEMOING M., BOISSEAU M. R Heparines de bas poids moléculaire et ulcères de jambes par micro-angiopathie utilisation des HBPM à dose curative dans 19 cas. Sem. Hop Paris, 1996 72 231-6
27. KAY R., KA SING WONG, YUEC LING YU and al. Low molecular-weight heparin for the treatment of acute ischemic stroke N. Engl J Med.. 1995 333 1588-93
28. Fragmin during instability in coronary artery disease (FRISC) study group Low molecular weight heparin during instability in coronary artery disease. Lancet, 1996. 347: 561-568.
29. ALBADA J , NIEUWENHUIS H K., SIXMA J.J Treatment of acute venous thromboembolism with low molecular weight hepalin (Fragmin) Results of a double-blind randomized study Circulation 1989. 80 935-40
30. LEVESQUE H , VERDER S , CAILLEUX N and al Low molecular weight heparins and hypoaldosteronism Br Med J., 1990. 300. 1437-8
31. WARKENTIN T.E , LEVINE M N., HIRSH J and al Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfracfionated heparin. N. Engl J. Med., 1995; 332 :1330-5.
32. VISENTIN G.P , FORD S E., SCOTT J P . ASTER R H antibodies from patients with heparin induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells J Clin Invest 1994; 93 81-8
33. MANCIET G , LATAPIE M J . VERGNES C , DECAMPS A , BOURDENX V., BOURDEL I , BOISSEAU M.R Héparines et remodelage osseux. Evolution de l'ostéocalcine au cours d'une héparinothérapie préventive prolongée Bulletin de l ACOMEN, 1989, 2. 113-118.
34. ARIACH M., BONEU B., PATRON G. Utilisation des héparines en pratique médicale courante Recommandations du Groupe d'études sur l Hémostase et la Thrombose S T V.. 1991, 3 supplt au no 5. 4-10.